187 related articles for article (PubMed ID: 31863667)
1. Th1 Chemokines in Autoimmune Endocrine Disorders.
Fallahi P; Ferrari SM; Ragusa F; Ruffilli I; Elia G; Paparo SR; Antonelli A
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31863667
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in thyroid autoimmunity.
Ferrari SM; Paparo SR; Ragusa F; Elia G; Mazzi V; Patrizio A; Ghionzoli M; Varricchi G; Centanni M; Ulisse S; Antonelli A; Fallahi P
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101773. PubMed ID: 36907786
[TBL] [Abstract][Full Text] [Related]
4. Role of chemokines in endocrine autoimmune diseases.
Rotondi M; Chiovato L; Romagnani S; Serio M; Romagnani P
Endocr Rev; 2007 Aug; 28(5):492-520. PubMed ID: 17475924
[TBL] [Abstract][Full Text] [Related]
5. Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity.
Fallahi P; Ferrari SM; Corrado A; Giuggioli D; Ferri C; Antonelli A
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):95-101. PubMed ID: 24953644
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapies for Thyroid Autoimmune Diseases.
Fallahi P; Ferrari SM; Elia G; Nasini F; Colaci M; Giuggioli D; Vita R; Benvenga S; Ferri C; Antonelli A
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):853-61. PubMed ID: 26900630
[TBL] [Abstract][Full Text] [Related]
7. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.
Rotondi M; Lazzeri E; Romagnani P; Serio M
J Endocrinol Invest; 2003 Feb; 26(2):177-80. PubMed ID: 12739748
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease.
Bellastella G; Rotondi M; Pane E; Costantini S; Colella C; Calemma R; Capone F; Falorni A; Castello G; Sinisi AA; Bizzarro A; Chiovato L; Bellastella A; De Bellis A
J Endocrinol Invest; 2011 Dec; 34(11):831-4. PubMed ID: 21169727
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.
Edvardsen K; Bjånesøy T; Hellesen A; Breivik L; Bakke M; Husebye ES; Bratland E
J Interferon Cytokine Res; 2015 Oct; 35(10):759-70. PubMed ID: 25978633
[TBL] [Abstract][Full Text] [Related]
10. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
11. Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.
Magnusson L; Barcenilla H; Pihl M; Bensing S; Espes D; Carlsson PO; Casas R
Front Immunol; 2020; 11():288. PubMed ID: 32153591
[TBL] [Abstract][Full Text] [Related]
12. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
13. Altered chemokine Th1/Th2 balance in Addison's disease: relationship with hydrocortisone dosing and quality of life.
Ekman B; Alstrand N; Bachrach-Lindström M; Jenmalm MC; Wahlberg J
Horm Metab Res; 2014 Jan; 46(1):48-53. PubMed ID: 23918683
[TBL] [Abstract][Full Text] [Related]
14. The Th1 chemokine MIG in Graves' ophthalmopathy.
Gonnella D
Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines.
Ferrari SM; Antonelli A; Di Domenicantonio A; Manfredi A; Ferri C; Fallahi P
Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):132-8. PubMed ID: 24953713
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.
Rotondi M; Falorni A; De Bellis A; Laureti S; Ferruzzi P; Romagnani P; Buonamano A; Lazzeri E; Crescioli C; Mannelli M; Santeusanio F; Bellastella A; Serio M
J Clin Endocrinol Metab; 2005 Apr; 90(4):2357-63. PubMed ID: 15657375
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in hyperthyroidism.
Ferrari SM; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Antonelli A; Fallahi P
J Clin Transl Endocrinol; 2019 Jun; 16():100196. PubMed ID: 31193493
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine.
Corrado A; Ferrari SM; Ferri C; Ferrannini E; Antonelli A; Fallahi P
Clin Ter; 2014; 165(2):e181-5. PubMed ID: 24770831
[TBL] [Abstract][Full Text] [Related]
19. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
[TBL] [Abstract][Full Text] [Related]
20. Novel therapies for thyroid autoimmune diseases: An update.
Ferrari SM; Fallahi P; Elia G; Ragusa F; Camastra S; Paparo SR; Giusti C; Gonnella D; Ruffilli I; Shoenfeld Y; Antonelli A
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101366. PubMed ID: 31813786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
